# Lululab

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lululab

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.lulu-lab.com/
- Total disclosed funding: $1.6M
- Latest round: Series C (Jul 12, 2022)
- Investors on record: 10

## About

Lululab, Inc. offers cutting-edge skin analysis technology, utilizing AI to provide precise diagnostics. Their innovative solutions cater to both consumers and businesses in the beauty and healthcare sectors, enhancing personalized skincare experiences. Lululab, Inc. specializes in skin analysis technology, founded in 2017 in Seoul, South Korea. In June 2026,?Lululab, Inc. raised? KRW 15 billion in pre-IPO funding from new investors Helios Ventures.

Lululab, Inc.specializes in advanced skin analysis technology, leveraging a proprietary algorithm and AI to deliver precise diagnostics for consumers. Their core product offerings include the Lumini Kiosk and Lumini Home solutions, both designed to provide detailed assessments of various skin conditions within a mere seven seconds of imaging. Key skin metrics evaluated include acne types, fine lines, pigmentation, and skin tone darkness, enabling users to receive tailored skincare recommendations. LULULAB primarily targets both individual consumers and businesses in the beauty and healthcare sectors, enhancing customer experience and satisfaction through self-service solutions. The company's products are available in multiple international markets, facilitating access for diverse customer bases seeking innovative skincare insights.

Lululab, Inc. generates revenue primarily through direct-to-consumer sales and B2B partnerships. The transaction structure typically involves consumers utilizing the Lumini Kiosk at retail locations or purchasing the Lumini Home device for personal use, with revenues derived from both initial product sales and ongoing subscriptions for premium services. Their offerings are positioned to cater to a broad clientele, including beauty retailers and health clinics, enhancing the value proposition through advanced skin analysis and personalized product recommendations. The company's flagship products, such as the Lumini Kiosk and the associated skincare curation services, form the backbone of their revenue strategy, promoting continuous engagement through tailored skincare solutions.

The company will use the July 2022 series C funding to enhance its technology and support global expansion. The company plans to launch new products and expand into additional international markets, leveraging the recent funding to accelerate these initiatives.

## Funding rounds

- Series C, Jul 12, 2022, $1.6M — Woowa Brothers Corp., SK Shieldus Co., Ltd., Nautic Investment, Hyundai Motor Securities, Accurus Group, Elohim Partners
- Series B, Nov 13, 2020 — Netmarble, CTK Investment, L&C Bio Co., Ltd., Global Medical Research Institute Inc

## Investors

- Netmarble — Series B
- CTK Investment (https://capitalatlas.ai/funds/ctk-investment) — Series B
- L&C Bio Co., Ltd. — Series B
- Global Medical Research Institute Inc — Series B
- Woowa Brothers Corp. — Series C
- SK Shieldus Co., Ltd. — Series C
- Nautic Investment (https://capitalatlas.ai/funds/nautic-investment) — Series C
- Hyundai Motor Securities — Series C
- Accurus Group — Series C
- Elohim Partners (https://capitalatlas.ai/funds/elohim-partners) — Series C